Retained intrauterine contraceptive device in pregnancy, second trimester
ICD-10 O26.32 is a billable code used to indicate a diagnosis of retained intrauterine contraceptive device in pregnancy, second trimester.
The diagnosis O26.32 refers to the presence of a retained intrauterine contraceptive device (IUD) during the second trimester of pregnancy. This condition can complicate pregnancy due to potential risks such as miscarriage, preterm labor, and infection. The presence of an IUD can lead to abnormal placentation, which may result in placental abruption or previa. Management typically involves careful monitoring and may require removal of the device if it poses a significant risk to the mother or fetus. The clinical approach should include a thorough assessment of maternal health, including any underlying conditions such as renal, cardiac, or respiratory issues that may complicate the pregnancy further. The healthcare provider must evaluate the risks versus benefits of intervention, considering the gestational age and the health of both the mother and fetus.
Detailed documentation of the patient's obstetric history, current pregnancy status, and any interventions performed regarding the IUD.
Management of a patient presenting with retained IUD during routine prenatal visits or emergency care.
Consideration of maternal health conditions such as hypertension or diabetes that may affect treatment options.
Comprehensive documentation of maternal-fetal assessments, including ultrasound findings and any interventions related to the IUD.
High-risk pregnancies where the presence of an IUD may lead to increased monitoring and potential surgical intervention.
Focus on the implications of the retained IUD on fetal development and maternal health.
Used when the retained IUD poses a risk to the pregnancy and requires removal.
Document the indication for removal and any complications encountered during the procedure.
Obstetricians should ensure that the procedure is justified based on maternal and fetal health.
Documentation should include the presence of the retained IUD, any complications arising from it, the trimester of pregnancy, and any maternal health conditions that may affect management.
